Published in Clin Infect Dis on January 25, 2006
Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy. Antimicrob Agents Chemother (2007) 1.28
Plague gives surprises in the first decade of the 21st century in the United States and worldwide. Am J Trop Med Hyg (2013) 1.17
Levofloxacin cures experimental pneumonic plague in African green monkeys. PLoS Negl Trop Dis (2011) 0.92
Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance. Antimicrob Agents Chemother (2010) 0.88
Sodium-glucose transporter-2 (SGLT2; SLC5A2) enhances cellular uptake of aminoglycosides. PLoS One (2014) 0.83
Comparative efficacies of candidate antibiotics against Yersinia pestis in an in vitro pharmacodynamic model. Antimicrob Agents Chemother (2011) 0.83
Septicemic plague in a community hospital in California. Am J Trop Med Hyg (2008) 0.83
Salicylic acid attenuates gentamicin-induced nephrotoxicity in rats. ScientificWorldJournal (2012) 0.77
Plague in China 2014-All sporadic case report of pneumonic plague. BMC Infect Dis (2016) 0.75
New opportunities to fight against infectious diseases and to identify pertinent drug targets with novel methodologies. Infect Disord Drug Targets (2009) 0.75
Successful Treatment of Human Plague with Oral Ciprofloxacin. Emerg Infect Dis (2017) 0.75
The potential and challenges of nanopore sequencing. Nat Biotechnol (2008) 14.24
Iniparib plus chemotherapy in metastatic triple-negative breast cancer. N Engl J Med (2011) 4.94
Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance. Chest (2004) 2.15
Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer. Anticancer Res (2011) 1.14
Chemical-biological ocular injury from turkey bile. Cutan Ocul Toxicol (2011) 0.96
Discovery of the first C-nucleoside HCV polymerase inhibitor (GS-6620) with demonstrated antiviral response in HCV infected patients. J Med Chem (2013) 0.93
Discovery of GS-9451: an acid inhibitor of the hepatitis C virus NS3/4A protease. Bioorg Med Chem Lett (2012) 0.92
Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides. Bioorg Med Chem Lett (2012) 0.83
Synthesis and characterization of 2'-C-Me branched C-nucleosides as HCV polymerase inhibitors. Bioorg Med Chem Lett (2012) 0.80
Home-anticoagulation testing: accuracy of patient-reported values. J Surg Res (2007) 0.80
(1)H HR-MAS spectroscopy for quantitative measurement of choline concentration in amniotic fluid as a marker of fetal lung maturity: inter- and intraobserver reproducibility study. J Magn Reson Imaging (2008) 0.79
Basic life support providers' assessment of centre of the chest and inter-nipple line for hand position and their underlying anatomical structures. Resuscitation (2010) 0.78
Reduction of MIC of azithromycin for Salmonella typhi and Staphylococcus aureus in broth exposed to previous growth of Salmonella typhi. J Antimicrob Chemother (2002) 0.77
Characterization of ryanodine receptor-mediated calcium release in human B cells: relevance to diagnostic testing for malignant hyperthermia. Anesthesiology (2006) 0.76
Loperamide for the treatment of traveler's diarrhea: broad or narrow usefulness? Clin Infect Dis (2008) 0.75